Purpose: Opioids are important in the care of critically ill children. However, their use is associated with complications including delirium, dependence, withdrawal, and bowel dysfunction. Our aim was to implement a risk-stratified opioid weaning protocol to reduce the duration of opioids without increasing the incidence of withdrawal.
Methods: A pre- and post-interventional prospective study was undertaken in a large children's hospital pediatric ICU where we implemented a risk-stratified opioid weaning protocol. Patients were included if exposed to ≥7days of scheduled opioids. The primary outcome was duration of opioids and secondary outcome was hospital LOS.
Results: One hundred seven critically ill children met the inclusion criteria (68 pre-, 39 post-intervention). Demographics, risk factors, and confounders did not differ between groups. Patients in the post-intervention group had shorter duration of opioids (17 vs. 22.5days, p=0.01) and opioid wean (12 vs. 18days, p=0.01). Despite the shorter duration of opioid wean, there was no increase in withdrawal incidence. There was no difference in the LOS (29 vs. 33days, p=0.06).
Conclusions: We implemented a risk-stratified opioid weaning protocol for critically ill children that resulted in reduction in opioid exposure without an increase in withdrawal. There was no difference in the LOS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jcrc.2017.08.049 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cost-Benefit Analysis of a Pediatric ICU Sedation Weaning Protocol.
J Pediatr Pharmacol Ther
October 2024
Departments of Pediatric Critical Care (KB) and Pharmacy (JA), Monroe Carell Jr. Children's Hospital at Vanderbilt University Medical Center, Nashville, TN.
Article Synopsis
- A retrospective study in a pediatric intensive care unit assessed the impact of a risk stratified sedation weaning protocol on medication costs and patient outcomes over a two-year period.
- The results showed that implementing the protocol reduced total sedation weaning costs significantly from approximately $400,329 to around $170,459, with lower median costs per patient.
- Despite the cost reduction, the incidence of withdrawal symptoms before and after the protocol remained similar, indicating that patient outcomes were not adversely affected by the change.
Opioid-Free Discharge After Pancreatic Resection Through a Learning Health System Paradigm.
JAMA Surg
November 2023
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Importance: Postoperative opioid overprescribing leads to persistent opioid use and excess pills at risk for misuse and diversion. A learning health system paradigm using risk-stratified pancreatectomy clinical pathways (RSPCPs) may lead to reduction in inpatient and discharge opioid volume.
Objective: To analyze the outcomes of 2 iterative RSPCP updates on inpatient and discharge opioid volumes.
Testing the Decision Support Tool for Responsible Pain Management for Headache and Facial Pain Diagnosis with Opioid-Risk-Stratified Treatment.
SN Compr Clin Med
February 2023
Internal Medicine, University of Iowa, Iowa City, IA 52242 USA.
In primary and urgent care, headache and facial pain are common and challenging to diagnose and manage, especially with using opioids appropriately. We therefore developed the Decision Support Tool for Responsible Pain Management (DS-RPM) to assist healthcare providers in diagnosis (including multiple simultaneous diagnoses), workup (including triage), and opioid-risk-informed treatment. A primary goal was to supply sufficient explanations of DS-RPM's functions allowing critique.
View Article and Find Full Text PDFDifferential Gains in Surgical Outcomes for High-Risk vs Low-Risk Pancreaticoduodenectomy with Successive Refinements of Risk-Stratified Care Pathways.
J Am Coll Surg
July 2023
From the Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.
Background: The use of risk-stratified pancreatectomy care pathways (RSPCPs) is associated with reduced length of stay (LOS). This study sought to evaluate the impact of successive pathway revisions with the hypothesis that high-risk patients require iterative pathway revisions to optimize outcomes.
Study Design: A prospectively maintained database (October 2016 to December 2021) was evaluated for pancreaticoduodenectomy patients managed with RSPCPs preoperatively assigned based on postoperative pancreatic fistula (POPF) risk.
Comparative analysis of opioid use between robotic and open pancreatoduodenectomy.
J Hepatobiliary Pancreat Sci
April 2023
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Background/purpose: Risk-stratified pancreatectomy clinical pathways using regional anesthesia and multimodality analgesia have decreased overall opioid use, but the additional benefits of robotic surgery in opioid reduction for pancreatoduodenectomy (PD) are unknown. We compared the inpatient opioid use between robotic PD and open PD.
Methods: Patients undergoing open PD within a protocol evaluating preincisional regional anesthetic block bundles were compared to consecutively-treated patients undergoing robotic PD identified from a prospectively maintained single-institutional database.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!